Abiopharma

Trustee report for the company’s BONDS Series 1 for 2025, Mishmeret

Invitation to a special meeting on 22.7.26 – arrangement for delimiting activity with BIG Shopping Centers – voting ballot

Register of shareholders, changes and capital status – exercise of employee warrants

Tender for issuance of BONDS (Series 6) to classified investors on 15.6.26

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting

Change in holdings of interested parties/officers

IQM任命Vanguard董事、前Deloitte Digital全球负责人Barbara Venneman为董事会成员

IQM任命Vanguard董事、前Deloitte Digital全球負責人Barbara Venneman為董事會成員

IQM、バンガード取締役でデロイト デジタル元グローバル責任者のバーバラ・ヴェネマンを取締役に任命

IQM nomina Barbara Venneman, Direttore del CdA di Vanguard ed ex Responsabile globale di Deloitte Digital, al suo consiglio di amministrazione